BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. nitric oxide metabolic process, Allergy to pollen, Liver, Early pregnancy factor)
Bookmark Forward

QuickView for epithelial to mesenchymal transition involved in endocardial cushion formation (biogroup)


Body Atlas

Most Correlated Tissues

  1. Urethra
  2. Myometrium
  3. Cervix
  4. Uterus
  5. Ovary
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Infection due to Citrobacter
  2. Pyloric ulcer
  3. Respiratory infection due to S. pneumoniae
  4. Anomaly of chromosome pair 6
  5. Craniolacunia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  2. A 443654
  3. CGP 60474
  4. AS 601245
  5. AT 7867
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ARX
  2. TFCP2L1
  3. PPP2R2C
  4. NR5A1
  5. CHMP2B
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
  2. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  4. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for epithelial to mesenchymal transition involved in endocardial cushion formation
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for epithelial to mesenchymal transition involved in endocardial cushion formation
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.